Graham Capital Management, L.P. Ani Pharmaceuticals Inc Transaction History

Graham Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$54.2 - $69.69 $95,554 - $122,863	-1,763 Reduced 34.59%	3,334 $230,000
Q4 2023 Feb 14, 2024	SELL	$48.72 - $65.43 $334,657 - $449,438	-6,869 Reduced 57.4%	5,097 $281,000
Q3 2023 Nov 22, 2023	BUY	$50.28 - $64.61 $374,435 - $481,150	7,447 Added 164.79%	11,966 $694,000
Q2 2023 Aug 14, 2023	BUY	$37.29 - $53.83 $168,513 - $243,257	4,519 New	4,519 $243,000
Q4 2022 Feb 14, 2023	BUY	$31.9 - $41.95 $278,933 - $366,810	8,744 New	8,744 $351,000

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.